IRCT2017100136491N1
Recruiting
Phase 2
Evaluation of clinical and histopathological efficacy of carboplatin and gemcitabine as second line neoadjuvant therapy in locally advanced breast cancer patients
Ministry of Research, Shiraz University of Medical Sciences, Pharmaceutical Sciences Research Center0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Breast cancer.
- Sponsor
- Ministry of Research, Shiraz University of Medical Sciences, Pharmaceutical Sciences Research Center
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female patients; Diagnosed with locally advanced breast cancer; 18 to 60 years of age. Exclusion criteria: Evidence of metastasis; Inflammatory breast cancer; Abnormal kidney function (Serum creatinine \> 1\.5 mg/dl); Abnormal liver function (Bilirubin and Serum transaminase \> 2xULN); Abnormal Bone marrow function (Abnormal hemoglobin, WBC and platelet count)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of the improvement of symptoms and of the vulva tissue in Lichen Sclerosus in patients with joint treatment of Anti-inflammatory Cream and the application of energy called RadiofrequencyRBR-3d3t8zdniversidade Federal Fluminense
Completed
Phase 3
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40
Completed
Not Applicable
evaluation of three different materials as base under restoration in deeply carious milk teeth clinically and radiographicallyHealth Condition 1: K029- Dental caries, unspecifiedCTRI/2020/12/029578dr durga r60
Recruiting
Not Applicable
Clinical and radiographic evaluation of the efficacy of pulpal revitalization treatment: randomized clinical trialDental pulp necrosis/regenerationC07.793.237.315RBR-336mnhniversidade Ceuma
Active, not recruiting
Phase 2
se of Simvastatin Gel for the treatment of Peri-implantitisperiimplantitisC07.465.714RBR-3bqywp7niversidade Estadual Paulista, Faculdade de Odontologia de Araraquara, FOAR-UNESP